← Eichor
Study identifier: NCT07316166 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine

Condition: Postoperative Pain Management  ·  Sponsor: Rhode Island Hospital

PhasePhase 4
Planned participants120
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The investigators are evaluating postoperative outcomes in patients undergoing hip replacement surgery performed with either spinal or general anesthesia, who also receive a suprainguinal fascia iliaca block using either perineural ropivacaine alone or ropivacaine combined with dexmedetomidine.

This description comes directly from the study's public registry record.

Talk to the study team

Vendhan Ramanujam, M.D.  ·  401-444-5172  ·  vramanujam@brownhealth.org

Always discuss trial participation with your own doctor first.

Locations (1)

The Miriam HospitalProvidence, Rhode Island, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07316166